Odyssey Marine Exploration Notified of Nasdaq Minimum Bid Price Deficiency

What Happened

• Odyssey Marine Exploration, Inc. (OMEX) disclosed on July 24, 2026 (notice dated July 21, 2026) that the Nasdaq Listing Qualifications Department notified the company it failed to meet Nasdaq Listing Rule 5550(a)(2) — the $1.00 minimum bid price requirement — for 30 consecutive business days.
• Nasdaq has given Odyssey a 180-calendar day compliance period (ending January 19, 2027) to regain compliance by achieving a closing bid of at least $1.00 per share for ten consecutive business days. The notice does not have an immediate effect on the company’s Nasdaq listing.

Key Details

• Nasdaq notice date: July 21, 2026; cure period ends: January 19, 2027.
• To regain compliance: $1.00+ closing bid for at least 10 consecutive business days.
• If not cured, Odyssey may be eligible for an additional 180-day period if it meets other initial listing standards (except the minimum bid price) and provides written notice to Nasdaq.
• Odyssey previously disclosed a stockholder-approved reverse stock split (1-for-20 to 1-for-25) on June 1, 2026, which the company expects may enable it to regain compliance before the effective time of its proposed merger with American Ocean Minerals Corporation (AOM).

Why It Matters

• For investors, this notice signals a potential risk of future delisting if the company does not restore its share price to meet Nasdaq rules within the cure periods. Delisting could reduce liquidity and trading access for OMEX shares.
• The approved reverse stock split is the company’s disclosed remedy to raise the per-share price; it also may affect outstanding share count and per-share metrics. The merger with AOM remains pending and could be impacted by timing of compliance and corporate actions. The notice is procedural — trading continues for now — but investors should monitor stock price, any split implementation, and merger filings (including the S-4/proxy statement).